Aller au contenu principal
Profil bibliographique

Zaid Sirhan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

10Publications signalées
106Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Glioma Diagnosis and TreatmentPI3K/AKT/mTOR signaling in cancerHER2/EGFR in Cancer ResearchNeuroblastoma Research and TreatmentsCancer Immunotherapy and Biomarkers

Les publications récentes

Accès ouvert 2025 article OpenAlex

H2AX phosphorylation driven by the SET-PP2A axis maintains glioma stem cell properties

Chunhua Han, Na Li, Ananya Tina Banerjee, Linzhou Wang et autres

Glioblastoma harbors a subpopulation of glioma stem cells (GSCs) that drive tumor relapse and invasion. Although GSC properties are known to be regulated by key transcription factors and chromatin remodeling, the mechanisms governing stemness-associated gene expression and the role of histone proteins …

us (code pays fourni par la source)

1 citation Genes & Diseases
Accès ouvert 2025 article OpenAlex

Metformin-Based Combination Approaches for Triple-Negative Breast Cancer

Zaid Sirhan, Aya Abu Nada, Nadeen Anabtawi, Anita Thyagarajan et autres

Numerous anti-diabetic medications, including metformin, have been explored for their anticancer effects because of the substantial correlation between diabetes and cancer incidence. Metformin has recently gained interest for its anticancer effects against malignancies such as breast cancer, one of the leading causes …

us, qa (code pays fourni par la source)

10 citations Pharmaceutics
Accès ouvert 2025 article OpenAlex

Impact of the crosstalk between the PTEN and PAFR as well as PAFR and EGFR pathways in cancer

Anita Thyagarajan, Zaid Sirhan, Ravi P. Sahu

The integration between the tumor-suppressive and oncogenic signaling pathways controls various cellular activities of cancer cells, including cell growth and apoptosis. While the activation of oncogenes fuels cancer progression and escape mechanisms, tumor suppressors regulate and counterbalance the negative effects of oncogenic …

us, th (code pays fourni par la source)

0 citations Exploration of Drug Science
Accès ouvert 2024 conference-abstract OpenAlex

BIOM-41. HMGB2 IS A CANDIDATE PROGNOSTIC BIOMARKER IN BOTH ADULT AND PEDIATRIC DIFFUSE GLIOMAS

Aline Paixão Becker, Valesio Becker, Zaid Sirhan, Joseph McElroy et autres

Abstract Few prognostic molecular markers are common to pediatric- and adult diffuse gliomas (PDG and ADG). HMGB2 is a protein expressed in human brain development and in de-differentiated high-grade gliomas (HGG), which we have recently described as a putative prognostic and predictive …

us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2023 conference-abstract OpenAlex

BIOL-05. IDENTIFICATION AND VALIDATION OF PA2G4 AS A POTENTIAL THERAPEUTIC TARGET IN PEDIATRIC DIFFUSE GLIOMAS

Zaid Sirhan, Blake E. Sells, Jessica L. Fleming, H. Manring et autres

Abstract Brain tumors are the second most common pediatric malignancy after leukemia. High grade gliomas have a significantly high morbidity and mortality in children, with a 5-year survival rate under 20%. This study aims to identify important biological mechanisms and proteins as …

us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2023 article OpenAlex

Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer

Aya Abunada, Zaid Sirhan, Anita Thyagarajan, Ravi P. Sahu

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) accounts for about 20% to 30% of all BC subtypes and is characterized by invasive disease and poor prognosis.With the emergence of anti-HER2 target drugs, HER2-positive BC patient outcomes have changed dramatically.However, …

qa, us (code pays fourni par la source)

6 citations World Journal of Clinical Oncology
Accès ouvert 2022 article OpenAlex

The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer

Zaid Sirhan, Anita Thyagarajan, Ravi P. Sahu

Overexpression of human epidermal growth factor receptor 2 (HER2) occurs in approximately 15-20% of breast cancer cases. HER2 is a member of the epidermal growth factor receptor (EGFR) family with tyrosinase kinase activity, and its overexpression is linked to poor prognosis and …

us (code pays fourni par la source)

62 citations Military Medical Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.